The effect of thermal therapy on uremic pruritus and quality of life in patients undergoing hemodialysis
Not Applicable
- Conditions
- uremic pruritus.L80-L99Other disorders of the skin and subcutaneous tissue
- Registration Number
- IRCT2017041333245N2
- Lead Sponsor
- Deputy of Research and Technology of Shahed University;Elderly Research Center of Shahed University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
The inclusion criteria were:
=18 years of age; able to communicate in persian; a diagnosis of uremia, confirmed in writing by the primary care physician; receiving haemodialysis three times a week for at least three months; having pruritus symptoms; being fully conscious. participants were excluded if they had any dermatological disorders; haematological disorders; organic problems or current use of drugs that might contradict or interfere with the assessments of outcomes; current requirement for haemodialysis more than three times per week due to comorbidity; Individuals who were unable or unwilling to follow the thermal therapy protocol for any reason were excluded from the trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method remic pruritus. Timepoint: Pre-Test:Before the intervention;Mid-Test:After 1 month from the beginning of the intervention.Post-Test:After two months and 18 sessions of heat therapy. Method of measurement: location and severity of uremic pruritus assessed by questionnaire and a visual analogue scale (VAS).
- Secondary Outcome Measures
Name Time Method ife quality. Timepoint: Pre-Test:Before the intervention;Mid-Test:After 1 month from the beginning of the intervention.Post-Test:After two months and 18 sessions of heat therapy. Method of measurement: Assesed byquestionnaire(KDQOL- SF)Quality of life for patients with ESRD(Itchy Qol).;Biochemical indicators. Timepoint: Before thermal therapy 1 (pre-test), and middle thermal therapy 2 (mid-test),After thermal therapy 3 (post-test) months. Method of measurement: Secondary outcome measures included several biochemical indicators.